Next-Generation Non-Genetic Multimodal Stimulation with O-GRAIN Nanoparticles
The existing diamond photonic layer stack is expanded with advanced multimodal capabilities:
Orchestrates the superposition timing
Global field priming
(Repurposed) Delivers O-GRAIN nanoparticles or drugs
NEW: Stores biocompatible optoacoustic nanoparticles
NEW: 1–5 MHz focused ultrasound, cavitation-free
1064 nm FMCW Lidar + 470/590 nm optogenetics
Beam steering for both optical and acoustic paths
Encapsulation
Biocompatible nanoparticles (gold nanoshells, carbon nanotubes, or diamond color centers) delivered via the electrophoresis array. They act as microscopic transducers embedded in tissue, converting combined optical and acoustic energy directly into localized electrical current.
The Q128 processor synchronizes three energy fields to arrive at the same voxel simultaneously:
The multi-modal approach combines three distinct physical pathways:
The 1064nm beam causes localized absorption and thermoelastic expansion, creating a tiny pressure wave.
1–5MHz focused ultrasound creates mechanical pressure and membrane modulation, lowering activation thresholds.
Sub-threshold localized displacement current provides electrical priming.
Nanoparticles absorb optical and acoustic energy, converting to highly localized current at field intersection points.
New safety theorems for multi-modal operation:
Limit: ΔT ≤ 0.05°C
Tool: SPARK thermal model + SymbiYosys hardware fuse
Limit: Mechanical Index < 0.1
Tool: Rust + Kani bubble dynamics model
Limit: ≤ 30 µC/cm²
Tool: SPARK charge limiter
ISO 10993 certification
Biocompatibility verification
For all stimulation patterns p, if p is approved by the Safety Monitor, then the combined thermal load (Lidar + Ultrasound), mechanical pressure (Ultrasound), and charge injection (DVNI) at any voxel do not exceed IEC 60601-2-33, IEC 60825-1, and ISO 14708-3 limits.
A method for non-genetic neural stimulation, comprising:
(a) delivering a plurality of optoacoustic nanoparticles (O-GRAINs) to a target tissue region via an electrophoretic array;
(b) simultaneously illuminating said region with a frequency-modulated continuous-wave (FMCW) lidar beam at 1064 nm;
(c) simultaneously applying focused ultrasound at 1–5 MHz to said region; and
(d) applying a sub-threshold electrical field via a DVNI electrode array,
wherein the superposition of said optical, mechanical, and electrical fields at a specific voxel causes the O-GRAINs to transduce energy into a localized current, thereby stimulating neurons without genetic modification.
The method of claim 12, wherein the FMCW lidar simultaneously measures the range and Doppler velocity of the O-GRAINs to verify their spatial co-localization with the ultrasound focus.
| Feature | Optogenetics (Previous) | Non-Genetic Superposition (New) |
|---|---|---|
| Genetic Modification | Required (AAV) | None |
| Onset Time | Weeks (transfection) | Immediate |
| Reversibility | Permanent | Instant (fields off) |
| Immune Response | High (viral vectors) | Low (biocompatible) |
| Safety Verification | Difficult (biological) | Provable (physics-based) |
| BOM Cost | High (AAV production) | Low (O-GRAIN synthesis) |
Three overlapping energy fields create the superposition region where all modalities intersect:
Optical Field ∩ Mechanical Field ∩ Electrical Field = Superposition Region